December 28, 2022 – The Ninth Circuit has reversed the district court’s dismissal of Hubbard v. Google et al., a proposed class action brought on behalf of minor children who viewed YouTube videos on certain YouTube “channels” geared towards children. Plaintiffs …
Ninth Circuit Reverses Dismissal of Children’s Privacy Class Action Read More »
October 12, 2022 – Pritzker Levine is pleased to announce that the firm will be honored by the American Antitrust Institute’s Antitrust Enforcement Awards for their work in In re EpiPen Marketing, Sales Practices and Antitrust Litigation. Pritzker Levine will be …
September 1, 2022 – Pritzker Levine is pleased to announce that partner Elizabeth C. Pritzker has been named the 2022 “Antitrust Lawyer of the Year” by the Antitrust and Unfair Competition Law Section of the California Lawyers Association. Elizabeth will …
Elizabeth C. Pritzker Named the 2022 “Antitrust Lawyer of the Year” Read More »
July 11, 2022 – Judge Daniel D. Crabtree has granted final approval to the $264 million settlement between Plaintiffs and the Mylan Defendants in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, finding the settlement to …
March 1, 2022 – Plaintiffs in In re: EpiPen Marketing, Sales Practices and Antitrust Litigation, MDL No. 2785, have reached a $264 million settlement with the Mylan Defendants to resolve class claims that Mylan, together with the Pfizer Defendants, engaged …
Plaintiffs Reach Settlement with the Mylan Defendants in EpiPen Class Action Read More »